- Home
- ANIK vs SGMO Comparison
ANIK vs SGMO Comparison
Compare ANIK & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIK
- SGMO
- Stock Information
- Founded
- ANIK 1983
- SGMO 1995
- Country
- ANIK United States
- SGMO United States
- Employees
- ANIK N/A
- SGMO N/A
- Industry
- ANIK Medical/Dental Instruments
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ANIK Health Care
- SGMO Health Care
- Exchange
- ANIK Nasdaq
- SGMO Nasdaq
- Market Cap
- ANIK 133.1M
- SGMO 122.8M
- IPO Year
- ANIK 1993
- SGMO 2000
- Fundamental
- Price
- ANIK $8.67
- SGMO $0.50
- Analyst Decision
- ANIK Buy
- SGMO Strong Buy
- Analyst Count
- ANIK 1
- SGMO 7
- Target Price
- ANIK $15.00
- SGMO $5.29
- AVG Volume (30 Days)
- ANIK 99.5K
- SGMO 4.5M
- Earning Date
- ANIK 10-30-2025
- SGMO 11-11-2025
- Dividend Yield
- ANIK N/A
- SGMO N/A
- EPS Growth
- ANIK N/A
- SGMO N/A
- EPS
- ANIK N/A
- SGMO N/A
- Revenue
- ANIK $114,548,000.00
- SGMO $81,706,000.00
- Revenue This Year
- ANIK N/A
- SGMO $21.24
- Revenue Next Year
- ANIK $5.33
- SGMO N/A
- P/E Ratio
- ANIK N/A
- SGMO N/A
- Revenue Growth
- ANIK 16.52
- SGMO 565.52
- 52 Week Low
- ANIK $7.87
- SGMO $0.41
- 52 Week High
- ANIK $26.00
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- ANIK 43.43
- SGMO 43.36
- Support Level
- ANIK $8.37
- SGMO $0.51
- Resistance Level
- ANIK $8.89
- SGMO $0.56
- Average True Range (ATR)
- ANIK 0.41
- SGMO 0.03
- MACD
- ANIK -0.00
- SGMO -0.00
- Stochastic Oscillator
- ANIK 20.55
- SGMO 29.08
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.